Neuroendocrine Prostate Cancer
Also known as: Neuroendocrine Prostate Cancer (NEPC)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB18472 | PT217 | 1 | Recruiting | 1 |
| DB17256 | Tarlatamab | 1 | Active Not Recruiting | 1 |
| DB01234 | Dexamethasone | 1 / 2 | Terminated | 1 |
| DB13017 | Rovalpituzumab tesirine | 1 / 2 | Terminated | 1 |
| DB05220 | Alisertib | 2 | Completed | 1 |